BridgeBio Pharma, Inc. (BBIO)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 6, 2026
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jun 30, 2026, BridgeBio Pharma, Inc. reported revenue of $243.7M, net income of -$152.2M, and total assets of $1.22B. Every figure below is taken directly from BridgeBio Pharma, Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2019–FY2025 · as reported
- FY2019 revenue
- $40.6M
- FY2025 revenue
- $502.1M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $502.1M | -$724.9M |
| FY2024 | $221.9M | -$535.8M |
| FY2023 | $9.3M | -$643.2M |
| FY2022 | $77.6M | -$481.2M |
| FY2021 | $69.7M | -$562.5M |
| FY2020 | $8.2M | -$448.7M |
| FY2019 | $40.6M | -$260.6M |
| FY2018 | — | -$130.7M |
| FY2017 | — | -$30.6M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Oct 29, 2026 | on EDGAR ↗ |
| 8-K | Oct 13, 2026 | on EDGAR ↗ |
| 8-K | Aug 31, 2026 | on EDGAR ↗ |
| 8-K | Aug 17, 2026 | on EDGAR ↗ |
| 8-K | Aug 10, 2026 | on EDGAR ↗ |
| 10-Q | Aug 10, 2026 | on EDGAR ↗ |
| 8-K | Jul 22, 2026 | on EDGAR ↗ |
| 8-K | Jul 2, 2026 | on EDGAR ↗ |
| 8-K | Jun 26, 2026 | on EDGAR ↗ |
| 8-K | May 27, 2026 | on EDGAR ↗ |
Balance Sheet
as of Jun 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jun 30, 2026
| Revenue | $243.7M | Revenue | source ↗ |
| Net Income | -$152.2M | Net | source ↗ |
| Operating Income | -$107.1M | Operating | source ↗ |
| Gross Profit | $228.6M | Revenue−Cost | source ↗ |
| Cost of Revenue | $15.0M | Cost | source ↗ |
| R&D Expense | $149.4M | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $-0.78 | Earnings | source ↗ |
| EPS (basic) | $-0.78 | Earnings | source ↗ |
| Shares Outstanding | 195.5M | Entity | source ↗ |
| Cash from Operations | -$71.1M | Net | source ↗ |
| Cash from Financing | -$148.8M | Net | source ↗ |
| Cash from Investing | $17.9M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 0
- Sells
- 56
- Net shares
- -567.1K
Restatement history
Point-in-time1 of 238 annual fact-keys were materially restated between filings: what BridgeBio Pharma, Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches BBIO’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BBIO
MCP tool:
get_sec_fundamentals ticker=BBIO - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BBIO/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=BBIO as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BBIO/history
MCP tool:
get_fundamentals_history ticker=BBIO - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/BBIO
MCP tool:
get_financial_health ticker=BBIO
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.